Immatics NV (Immatics NV) Research & Development : $133.32 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Immatics NV's Research & Development for the three months ended in Mar. 2024 was $34.90 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $133.32 Mil.

Immatics NV Research & Development Historical Data

The historical data trend for Immatics NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV Research & Development Chart

Immatics NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

44.55

81.61

98.95

113.11

129.40

Immatics NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															29.53	29.60	32.55	36.28	34.90

Immatics NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $133.32 Mil.

Immatics NV (NAS:IMTX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Immatics NV Research & Development Related Terms

Thank you for viewing the detailed overview of Immatics NV's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Immatics NV (Immatics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

4A3:Germany

Address

Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.immatics.com

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.